Tumor Biology

, Volume 36, Issue 11, pp 8273–8274 | Cite as

Does the elevation of serum carbohydrate antigen 19-9 level predict poor overall survival in patients with hepatocellular carcinoma?

  • Yan-Yan Wang
  • Jian-Hong Zhong
  • Zhan Lu
  • Hong-Gui Qin
  • Le-Qun Li
Commentary

Keywords

Carbohydrate antigen 19-9 Hepatocellular carcinoma Overall survival 

Notes

Compliance with ethical standards

Conflicts of interest

None

References

  1. 1.
    Duffy MJ, Sturgeon C, Lamerz R, Haglund C, Holubec VL, Klapdor R, et al. Tumor markers in pancreatic cancer: a European Group on Tumor Markers (EGTM) status report. Ann Oncol. 2010;21(3):441–7.CrossRefPubMedGoogle Scholar
  2. 2.
    Xiao J, He X, Wang Z, Hu J, Sun F, Qi F, et al. Serum carbohydrate antigen 19-9 and prognosis of patients with gastric cancer. Tumour Biol. 2014;35(2):1331–4.CrossRefPubMedGoogle Scholar
  3. 3.
    Kondo N, Murakami Y, Uemura K, Sudo T, Hashimoto Y, Sasaki H, et al. Elevated perioperative serum CA 19-9 levels are independent predictors of poor survival in patients with resectable cholangiocarcinoma. J Surg Oncol. 2014;110(4):422–9.CrossRefPubMedGoogle Scholar
  4. 4.
    Yu T, Yu H, Cai X. Preoperative prediction of survival in resectable gallbladder cancer by a combined utilization of CA 19-9 and carcinoembryonic antigen. Chin Med J (Engl). 2014;127(12):2299–303.Google Scholar
  5. 5.
    Zhang J, Huang T, Zhang F, Xu J, Chen G, Wang X, et al. Prognostic role of serum carbohydrate antigen 19-9 levels in patients with resectable hepatocellular carcinoma. Tumour Biol. 2015;36(4):2257–61.CrossRefPubMedGoogle Scholar
  6. 6.
    El-Serag HB. Hepatocellular carcinoma. N Engl J Med. 2011;365(12):1118–27.CrossRefPubMedGoogle Scholar
  7. 7.
    Bruix J, Sherman M. Management of hepatocellular carcinoma: an update. Hepatology. 2011;53(3):1020–2.CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Pissaia Jr A, Bernard D, Scatton O, Soubrane O, Conti F, Calmus Y. Significance of serum tumor markers carcinoembryonic antigen, CA 19-9, CA 125, and CA 15-3 in pre-orthotopic liver transplantation evaluation. Transplant Proc. 2009;41(2):682–4.CrossRefPubMedGoogle Scholar

Copyright information

© International Society of Oncology and BioMarkers (ISOBM) 2015

Authors and Affiliations

  • Yan-Yan Wang
    • 1
  • Jian-Hong Zhong
    • 1
  • Zhan Lu
    • 1
  • Hong-Gui Qin
    • 1
  • Le-Qun Li
    • 1
  1. 1.Department of Hepatobiliary SurgeryAffiliated Tumor Hospital of Guangxi Medical UniversityNanningChina

Personalised recommendations